SMAD2 and liver cancer: In summary, we demonstrated for the first time that proHp suppresses the TGF-β-induced EMT and cell invasion in vitro by enhancing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.